The antagonists may also be employed to prevent and/or treat hyperplasia and tumors in the lung, breast and other tissues.Antagonists to protein kinase C inhibitor protein may be employed to inhibit the activation function of protein kinase C.The antagonists may be employed therapeutically in a composition with a pharmaceutically acceptable carrier, e.g., as hereinafter described.The polypeptides